Endo Pharmaceuticals (ENDP) to Buy Indevus Pharmaceuticals (IDEV) For $370 Million, 45% Premium
Go back to Endo Pharmaceuticals (ENDP) to Buy Indevus Pharmaceuticals (IDEV) For $370 Million, 45% Premium| ENDO INTERNAT (NASDAQ: ENDP) | Delayed: 0.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $63.71 | |||
| Open | $0.02 | 52 Week Low | $12.56 | |||
| Day High | $0.29 | P/E | N/A | |||
| Day Low | $0.29 | EPS | $0.00 | |||
| Volume | 24,300 | |||||
| Indevus Pharmaceuticals, Inc. (NYSE: IDEV) | Delayed: 93.31 +1.03 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.28 | 52 Week High | $6.15 | |||
| Open | $93.39 | 52 Week Low | $1.51 | |||
| Day High | $93.41 | P/E | N/A | |||
| Day Low | $93.00 | EPS | $-0.77 | |||
| Volume | 970,056 | |||||
